The WHO Tailoring Immunization Programmes (TIP) approach: Review of implementation to date

Vaccine
Volume 36, Issue 11   Pages 1323-1520 (7 March 2018)
https://www.sciencedirect.com/journal/vaccine/vol/36/issue/11

The WHO Tailoring Immunization Programmes (TIP) approach: Review of implementation to date
Open access – Original research article
Pages 1509-1515
Eve Dubé, Julie Leask, Brent Wolff, Benjamin Hickler, … Katrine Habersaat
Abstract
Introduction
The WHO Regional Office for Europe developed the Guide to tailoring immunization programmes (TIP), offering countries a process through which to diagnose barriers and motivators to vaccination in susceptible low vaccination coverage and design tailored interventions. A review of TIP implementation was conducted in the European Region.
Material and methods
The review was conducted during June to December 2016 by an external review committee and was based on visits in Bulgaria, Lithuania, Sweden and the United Kingdom that had conducted a TIP project; review of national and regional TIP documents and an online survey of the Member States in the WHO European Region that had not conducted a TIP project. A review committee workshop was held to formulate conclusions and recommendations.
Results
The review found the most commonly cited strengths of the TIP approach to be the social science research as well as the interdisciplinary approach and community engagement, enhancing the ability of programmes to “listen” and learn, to gain an understanding of community and individual perspectives. National immunization managers in the Region are generally aware that TIP exists and that there is strong demand for the type of research it addresses. Further work is needed to assist countries move towards implementable strategies based on the TIP findings, supported by an emphasis on enhanced local ownership; integrated diagnostic and intervention design; and follow-up meetings, advocacy and incentives for decision-makers to implement and invest in strategies.
Conclusions
Understanding the perspectives of susceptible and low-coverage populations is crucial to improving immunization programmes. TIP provides a framework that facilitated this in four countries. In the future, the purpose of TIP should go beyond identification of susceptible groups and diagnosis of challenges and ensure a stronger focus on the design of strategies and appropriate and effective interventions to ensure long-term change.

Meningococcal Vaccines: Current Status and Emerging Strategies

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 3 March 2018)

Open Access Review
Meningococcal Vaccines: Current Status and Emerging Strategies
by Pumtiwitt C. McCarthy, Abeer Sharyan and Laleh Sheikhi Moghaddam
Vaccines 2018, 6(1), 12; doi:10.3390/vaccines6010012 – 25 February 2018
Abstract
Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis is a public health burden to both developed and developing countries throughout the world. There are a number of vaccines (polysaccharide-based, glycoconjugate, protein-based and combined conjugate vaccines) that are approved to target five of the six disease-causing serogroups of the pathogen. Immunization strategies have been effective at helping to decrease the global incidence of meningococcal meningitis. Researchers continue to enhance these efforts through discovery of new antigen targets that may lead to a broadly protective vaccine and development of new methods of homogenous vaccine production. This review describes current meningococcal vaccines and discusses some recent research discoveries that may transform vaccine development against N. meningitidis in the future

Vaccine hesitancy and trust.: Ethical aspects of risk communication

From Google Scholar & other sources: Selected Journal Articles, Newsletters, Dissertations, Theses, Commentary

  
Scandinavian Journal of Public Health
Epub ahead of print
Vaccine hesitancy and trust.: Ethical aspects of risk communication
J Nihlén Fahlquist
Abstract [en]
Aim: This paper analyses vaccination policy from an ethical perspective, against the background of the growing hesitancy towards e.g. the measles vaccine.
Methods: The paper is normative and analyses ethical aspects of risk communication in the context of vaccination. It is argued that ethical analysis of risk communication should be done at the level of the message, the procedure and the effects. The paper takes examples from the Swedish context, linking the current lack of trust in experts to the 2009 vaccination policy and communication promoting the H1N1 vaccine Pandemrix.
Results: During the Swedish H1N1 vaccination policy in 2009, the message was that the vaccine is safe. However, a group of adolescents developed narcolepsy as a side effect of the vaccine. Taking this into account, it becomes clear that the government should communicate risks and benefits responsibly and take responsibility for individuals affected negatively by populational health interventions.
Conclusion: To communicate respectfully entails not treating vaccine sceptics as ill-informed or less educated, but instead taking the concerns of the vaccine hesitant, who potentially could change their minds, as a starting-point of a respectful discussion. There will inevitably be individuals who suffer from side effects of justifiable population-based health promotion activities. However, the public should be able to trust the message and count on the government to take responsibility for individuals affected by side effects. This is important for normative reasons, but is additionally likely to contribute to restored and maintained trust.

Media/Policy Watch

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.

BBC
http://www.bbc.co.uk/
Accessed 3 March 2018
Government publishes key vaccine report [U.K.]
27 February 2018
A long-awaited report into how the government makes decisions about which vaccines to fund has been published.
It follows calls for greater transparency about why a vaccine to protect children against meningitis B was not made more widely available.
Two-year-old Faye Burdett died in 2016 – she was too old to have the vaccine.
An 820,000-signature petition calling for all children to be vaccinated was then submitted, – but the idea was rejected as “not cost effective”.
One of the recommendations in the report is lowering the cost-effectiveness threshold for immunisation, potentially making it harder for new vaccines to be approved at current prices.
Health Minister Steven Brine was due to face questions from MPs on Tuesday over why the report into the cost-effectiveness of immunisations – promised by the end of 2016 – still had not been published…
[See Milestones/Perspectives above for more detail]
 
Financial Times
http://www.ft.com/home/uk
Accessed 3 March 2018
To wipe out measles, governments must regain social trust
28 February 2018
Heidi Larson
[See Research, Reports above for full text]
 
Forbes
http://www.forbes.com/
Accessed 3 March 2018
This Company Is Testing A Flu Vaccine Made In Tobacco — And Philip Morris Is On Board
Arlene Weintraub, Contributor
As the FDA meets to plan next year’s flu vaccine, companies like Medicago are testing innovative technologies designed to minimize the risk of another devastating outbreak.
“Heard Immunity” — In An Age Of Vaccine Skepticism, It Is Critical To Understand Herd Immunity
Geoffrey Kabat, Contributor
The low vaccination rates for seasonal flu among Americans signal the need for better education of the public regarding the benefits of vaccines and the possibly dire consequences of of vaccine avoidance.
 
The Guardian
http://www.guardiannews.com/
Accessed 3 March 2018
Disgraced anti-vaxxer Andrew Wakefield aims to advance his agenda in Texas election
26 February 2018
Anti-vaccine campaigners have found a growing political voice for their debunked ideas in Texas, the adopted home of discredited British researcher Andrew Wakefield, and now hope to unseat a moderate Republican in the heart of Houston.
Texas has seen rates of children opting out of vaccines for philosophical reasons skyrocket after Wakefield – the man behind the UK’s MMR vaccine controversy in the early 2000s – moved to the state’s capital, Austin, more than a decade ago.
Since the early 2000s, when he arrived, the rate of Texas children exempted from at least one vaccine has shot up by 1,900% according to one analysis, while Houston has become a battleground for anti-vaccine activists of growing clout.
Now, Wakefield sees the upcoming Republican primary in Houston on 6 March as an “an extremely important time” to advance his anti-vaccine agenda….
 
 
New York Times
http://www.nytimes.com/
Accessed 3 March 2018
Opinion

All Children Should Have to Get the Flu Shot
The law requires vaccination for measles and mumps. Why not for this deadly virus?
March 1, 2018 By Ezekiel J. Emanuel and Justin Bernstein

They’re Hosting Parasitic Worms in Their Bodies to Help Treat a Neglected Disease
1 March 2018
Seventeen volunteers in the Netherlands have agreed to host parasitic worms in their bodies for 12 weeks in order to help advance research toward a vaccine for schistosomiasis, a chronic disease that afflicts more than 200 million people a year, killing thousands, primarily in sub-Saharan Africa and South America.

Middle East
Yemen’s Cholera Epidemic Likely to Intensify in Coming Months: WHO
The World Health Organization warned on Monday that a cholera epidemic in Yemen that killed more than 2,000 people could flare up again in the rainy season.
Feb. 26, 2018

Italy’s Vaccine Debate Shows Anti-Establishment Sway
26 February 2018
In Italy, the fight against measles has moved from the doctor’s office to the political battleground. The nation is facing one of its worst epidemics of measles in recent years, reporting a six-fold increase in cases last year that accounted for a quarter of all the cases in Europe. And yet the government’s response — a new law requiring parents to vaccinate their kids against measles and nine other childhood diseases — has become one of the most divisive issues going into March 4 general elections.

Washington Post
http://www.washingtonpost.com/
Accessed 3 March 2018
Five myths about outbreaks
No, closing borders can’t stop the spread of disease.
1 March 2018
By Seth Berkley